1. Home
  2. TXMD vs NOTV Comparison

TXMD vs NOTV Comparison

Compare TXMD & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$1.66

Market Cap

21.3M

Sector

Health Care

ML Signal

HOLD

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.56

Market Cap

23.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXMD
NOTV
Founded
2008
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.3M
23.0M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
TXMD
NOTV
Price
$1.66
$0.56
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
55.3K
418.8K
Earning Date
11-12-2025
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$2,796,000.00
$513,024,000.00
Revenue This Year
$427.09
$6.49
Revenue Next Year
N/A
$4.95
P/E Ratio
$275.53
N/A
Revenue Growth
75.19
4.54
52 Week Low
$0.70
$0.60
52 Week High
$2.44
$5.67

Technical Indicators

Market Signals
Indicator
TXMD
NOTV
Relative Strength Index (RSI) 50.93 27.01
Support Level $1.64 $0.61
Resistance Level $1.78 $0.69
Average True Range (ATR) 0.14 0.06
MACD -0.02 -0.00
Stochastic Oscillator 12.55 23.06

Price Performance

Historical Comparison
TXMD
NOTV

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: